GAS5 and neoplasm: (35) showed that GAS5 participates in facilitating tumor repression by directly binding EZH2, a member of the Polycomb inhibitory complex 2, further reducing lysine 27 trimethylation (H3K27me3) of histone H3, enhancing the expression of the target gene CDKN1C.